PATENT CLAIM ANALYSIS

Application Number: 16211722
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["514", "332000"]

Abstract:
The invention relates to compounds acting as selective antagonists of Transient Receptor Potential cation channel subfamily M member 8 (TRPM8), and having formula (I). Said compounds are useful in the treatment of diseases associated with activity of TRPM8 such as pain, inflammation, ischaemia, neurodegeneration, stroke, psychiatric disorders, itch, irritable bowel diseases, cold induced and/or exacerbated respiratory disorders and urological disorders.

Claim (Index 4):
A pharmaceutical composition comprising as the active ingredient at least one compound according to  claim 1  in combination with pharmaceutically acceptable excipients and/or diluents.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 98.0
- Lexical Diversity: 1.36364
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15321364', '14366796', '16061850', '15414803', '13982235']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7609511255131094
- 35 USC 102 Novelty (BERT): 0.5822070499084123
- Combined Prediction Score: 0.7430767179526396
- Mean Citation Score: 392.53767
- Max Citation Score: 459.34137
- Similarity Product: 450.5500118922544

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test